GLP-1 TV · Patient story · views checked Oct 2026
Wegovy Pill Hits 2 MILLION Prescriptions! But Novo Has a Problem
Our summary
A patient shares their experience with Ozempic. Also covers food noise and cravings, mood and mental health and injection technique.
One person's experience, in their words. Not medical advice.
Key moments
From the creator's own chapters. Tap one to play from there.
- 0:00 Wegovy Pill Hits 2 MILLION Prescriptions! But Novo Has a Pro
- 2:38 Novo’s GLP-1 Empire Faces a New Threat
- 8:42 Foundayo May Be Quieting Food Noise in the Brain
- 12:30 GLP-1s Are Replacing Bariatric Surgery for Some Patients
- 16:44 Employers Are Questioning GLP-1 Coverage Costs
- 19:49 Connecticut Targets Counterfeit Ozempic and Zepbound Sales
- 23:27 GLP-1 Users Face a New Kind of Weight Stigma
- 28:16 GLP-1s Linked to Lower AFib Risk in Major Study
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Ozempic, Wegovy, Zepbound and Mounjaro
- Who is speaking
- Patient
Find more like it
Dose changeWeigh-in and resultsFood noise and cravingsMood and mental healthInjection techniqueCost and insuranceExercise and strengthStopping and maintenanceHow it worksThe trials
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.